BATS BZX Real-Time Price
As of 9:59am ET
| +0.09 / +0.43%|
The 9 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 45.00, with a high estimate of 55.00 and a low estimate of 30.00. The median estimate represents a +114.59% increase from the last price of 20.97.
The current consensus among 9 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.